Published in EMBO J on August 06, 2013
MYC regulates the non-coding transcriptome. Oncotarget (2014) 1.29
miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet (2014) 1.25
Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nat Immunol (2014) 1.15
The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. Blood (2013) 0.96
MYC and the art of microRNA maintenance. Cold Spring Harb Perspect Med (2014) 0.94
miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells. PLoS One (2014) 0.93
MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC. PLoS One (2014) 0.92
An allelic series of miR-17 ∼ 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron. Nat Genet (2015) 0.92
Evolutionary conservation of primate lymphocryptovirus microRNA targets. J Virol (2013) 0.91
microRNA-17~92 is a powerful cancer driver and a therapeutic target. Cell Cycle (2014) 0.89
Therapeutic use of microRNAs in lung cancer. Biomed Res Int (2014) 0.87
Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer. Front Med (Lausanne) (2015) 0.85
The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential. Oncotarget (2015) 0.84
Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun (2016) 0.84
The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression. J Invest Dermatol (2015) 0.83
MicroRNA regulation of the germinal center response. Curr Opin Immunol (2014) 0.82
Synergy of Myc, cell cycle regulators and the Akt pathway in the development of aggressive B-cell lymphoma in a mouse model. Leukemia (2014) 0.80
Limited miR-17-92 overexpression drives hematologic malignancies. Leuk Res (2014) 0.80
Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response. Front Immunol (2015) 0.80
Transfection of microRNA Mimics Should Be Used with Caution. Front Genet (2015) 0.80
Small and Long Regulatory RNAs in the Immune System and Immune Diseases. Front Immunol (2014) 0.79
Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer. Breast Cancer Res Treat (2014) 0.79
A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog. PLoS Pathog (2016) 0.79
MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance. Biomed Res Int (2015) 0.77
Small RNA-mediated DNA (cytosine-5) methyltransferase 1 inhibition leads to aberrant DNA methylation. Nucleic Acids Res (2015) 0.77
Concurrent PI3K and NF-κB activation drives B-cell lymphomagenesis. Leukemia (2016) 0.75
A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore) (2016) 0.75
The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell Proliferation. Front Pharmacol (2017) 0.75
Japanese Macaque Rhadinovirus Encodes a Viral MicroRNA Mimic of the miR-17 Family. J Virol (2016) 0.75
miR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Hum Pathol (2015) 0.75
Differential Sensitivity of Target Genes to Translational Repression by miR-17~92. PLoS Genet (2017) 0.75
MicroRNAs: pleiotropic players in congenital heart disease and regeneration. J Thorac Dis (2017) 0.75
MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol Metab (2016) 0.75
Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation. Int Immunopharmacol (2015) 0.75
Frequent miRNA-convergent fusion gene events in breast cancer. Nat Commun (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
The functions of animal microRNAs. Nature (2004) 64.85
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell (2010) 17.87
Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet (2009) 16.58
microRNA functions. Annu Rev Cell Dev Biol (2007) 15.74
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature (2009) 14.07
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
microRNA target predictions in animals. Nat Genet (2006) 10.76
Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov (2009) 10.59
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol (2008) 10.42
Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer (2007) 10.27
Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet (2011) 9.79
MYC on the path to cancer. Cell (2012) 8.65
miRiad roles for the miR-17-92 cluster in development and disease. Cell (2008) 8.02
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A (2007) 7.93
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell (2008) 7.56
The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32
MicroRNA control in the immune system: basic principles. Cell (2009) 7.16
MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell (2008) 6.58
Molecular evolution of a microRNA cluster. J Mol Biol (2004) 5.94
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (1990) 5.63
Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci U S A (2004) 5.55
B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res (1997) 5.43
Maximizing mouse cancer models. Nat Rev Cancer (2007) 5.38
An E2F/miR-20a autoregulatory feedback loop. J Biol Chem (2006) 5.20
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci (2006) 5.11
TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol (2010) 4.92
The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol (2009) 4.61
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res (2009) 4.50
Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev (2009) 4.43
Translating insights from the cancer genome into clinical practice. Nature (2008) 4.37
The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33
Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol (2007) 4.16
Bethesda proposals for classification of lymphoid neoplasms in mice. Blood (2002) 4.07
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature (1991) 4.06
MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer (2011) 3.91
Desperately seeking microRNA targets. Nat Struct Mol Biol (2010) 3.85
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell (2005) 3.39
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell (2006) 3.31
Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol (2010) 3.30
E2f3 is critical for normal cellular proliferation. Genes Dev (2000) 3.26
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell (2012) 3.10
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem (2002) 3.05
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov (2012) 2.65
Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell (2002) 2.48
The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog (2012) 2.45
Pathogenesis of human B cell lymphomas. Annu Rev Immunol (2012) 2.44
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol (2010) 2.40
The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Mol Cell (2010) 2.38
Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene (2005) 2.36
The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res (2010) 2.13
Clinical applications for microRNAs in cancer. Clin Pharmacol Ther (2012) 2.05
Deubiquitinases in the regulation of NF-κB signaling. Cell Res (2010) 2.00
Burkitt lymphoma in the mouse. J Exp Med (2000) 1.96
Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell (2010) 1.85
Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood (2011) 1.80
miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev (2011) 1.66
Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol (2009) 1.63
Evolving views on the genealogy of B cells. Nat Rev Immunol (2008) 1.52
Role of transforming growth factor-beta in hematologic malignancies. Blood (2006) 1.41
Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol (2010) 1.41
The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol Rev (2012) 1.26
Suppression of survival signalling pathways by the phosphatase PHLPP. FEBS J (2012) 1.23
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J Exp Med (2010) 1.10
Survival analysis I: the Kaplan-Meier method. Nephron Clin Pract (2011) 1.00
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev (2003) 17.64
Regulation of the germinal center response by microRNA-155. Science (2007) 12.25
Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev (2005) 12.15
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (2004) 11.52
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol (2008) 10.42
Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell (2002) 10.30
MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell (2007) 9.33
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A (2003) 8.73
Sequence requirements for micro RNA processing and function in human cells. RNA (2003) 7.46
MicroRNA control in the immune system: basic principles. Cell (2009) 7.16
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol (2003) 7.06
Aberrant T cell differentiation in the absence of Dicer. J Exp Med (2005) 6.58
IgH class switching and translocations use a robust non-classical end-joining pathway. Nature (2007) 6.05
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A (2005) 5.88
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol (2006) 5.70
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J (2004) 5.67
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev (2005) 5.56
Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell (2008) 5.53
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science (2006) 5.31
MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature (2008) 5.29
Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity (2009) 5.10
A viral microRNA functions as an orthologue of cellular miR-155. Nature (2007) 5.09
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity (2008) 5.03
MicroRNA profiling of the murine hematopoietic system. Genome Biol (2005) 4.94
Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog (2006) 4.80
Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J (2004) 4.54
PI3 kinase signals BCR-dependent mature B cell survival. Cell (2009) 4.43
Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell (2004) 4.31
Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 4.01
Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res (2004) 3.81
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity (2006) 3.74
A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A (2004) 3.60
Vagaries of conditional gene targeting. Nat Immunol (2007) 3.51
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes Dev (2006) 3.44
Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol (2002) 3.42
Viruses, microRNAs, and host interactions. Annu Rev Microbiol (2010) 3.30
The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev (2009) 3.30
Regulation of microRNA expression and abundance during lymphopoiesis. Immunity (2010) 3.29
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature (2002) 3.21
Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog (2007) 3.16
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res (2006) 3.15
Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe (2008) 3.14
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell (2012) 3.10
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc Natl Acad Sci U S A (2011) 3.07
Yin Yang 1 is a critical regulator of B-cell development. Genes Dev (2007) 3.06
B cell receptor signal strength determines B cell fate. Nat Immunol (2004) 3.06
Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A (2002) 3.01
Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med (2012) 2.91
The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA (2007) 2.91
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif. Virology (2005) 2.84
PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol (2011) 2.82
Rapid generation of inducible mouse mutants. Nucleic Acids Res (2003) 2.77
Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J Virol (2004) 2.77
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology (2004) 2.75
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell (2010) 2.73
Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med (2009) 2.73
(CAG)(n)-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition. Nat Struct Mol Biol (2005) 2.71
A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing. J Virol (2006) 2.71
Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest (2003) 2.66
Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J Biol Chem (2005) 2.60
T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med (2004) 2.58
Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc Natl Acad Sci U S A (2003) 2.52
TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol (2004) 2.51
Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol (2008) 2.50
The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog (2012) 2.45
Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells. RNA (2003) 2.40
A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol (2004) 2.39
High-resolution description of antibody heavy-chain repertoires in humans. PLoS One (2011) 2.36
High speed detection of circulating tumor cells. Biosens Bioelectron (2006) 2.29
B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity (2007) 2.28
Case study of the morphologic variation of circulating tumor cells. Hum Pathol (2006) 2.28
Mechanisms promoting translocations in editing and switching peripheral B cells. Nature (2009) 2.27
Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA (2004) 2.21
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol (2012) 2.21
Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol (2005) 2.21
Mature T cells depend on signaling through the IKK complex. Immunity (2003) 2.21
Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest (2005) 2.20
Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J Virol (2005) 2.20
RNA interference in human cells is restricted to the cytoplasm. RNA (2002) 2.16
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe (2011) 2.13
FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses. Immunity (2006) 2.10
A mammalian herpesvirus uses noncanonical expression and processing mechanisms to generate viral MicroRNAs. Mol Cell (2010) 2.10
Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A (2004) 2.09
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Cancer Cell (2010) 2.09
Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res (2002) 2.03
Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol (2012) 2.02
IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med (2002) 1.93
Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol (2007) 1.93
Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J Exp Med (2010) 1.92
Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol (2004) 1.91
Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood (2002) 1.91
In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J Virol (2009) 1.90
c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity (2005) 1.87
Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol Cell Biol (2002) 1.86
Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell (2010) 1.85
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol (2005) 1.84